2017-01-14  -  PRINCIPAL SCIENTIST, IMMUNOLOGY  -    -  

GRAIL, Inc., is developing differentiated platforms for the early detection of cancer. These platforms combine approaches to ultradeep sequencing of circulating, cell-free nucleic acids with innovative clinical programs of the scale and quality required to generate strong scientific and clinical evidence of their utility. GRAIL’s software and computational biology efforts are commensurate to the size and complexity of the resulting data sets. We are seeking passionate and talented individuals to join us in realizing our mission, which has the potential to dramatically reduce the global burden of cancer. [More]

Originally posted on 2017-01-14
2017-01-08  -  STAFF BIOINFORMATICS SCIENTIST  -    -  

GRAIL, Inc. is developing paradigm-changing clinical assays for early cancer detection, based on unique biological insights from high-intensity sequencing analysis of circulating cell-free nucleic acids. GRAIL is seeking passionate and talented individuals to join us in realizing this mission, which has the potential to dramatically reduce the global burden of cancer. [More]

Originally posted on 2017-01-08
2016-12-14  -  Staff Bioinformatics Scientist  -    -  

GRAIL, Inc. is developing paradigm-changing clinical assays for early cancer detection, based on unique biological insights from high-intensity sequencing analysis of circulating cell-free nucleic acids. GRAIL is seeking passionate and talented individuals to join us in realizing this mission, which has the potential to dramatically reduce the global burden of cancer. [More]

Originally posted on 2016-12-14